| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0092-8674(83)90534-2 |
| P698 | PubMed publication ID | 6414718 |
| P2093 | author name string | Stewart T | |
| Lenoir G | |||
| Murphy W | |||
| Taub R | |||
| Leder P | |||
| Battey J | |||
| Potter H | |||
| Moulding C | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Burkitt lymphoma | Q1016605 |
| P304 | page(s) | 779-787 | |
| P577 | publication date | 1983-10-01 | |
| P1433 | published in | Cell | Q655814 |
| P1476 | title | The human c-myc oncogene: structural consequences of translocation into the IgH locus in Burkitt lymphoma | |
| P478 | volume | 34 |
| Q40064469 | A 10-base-pair element of the human immunodeficiency virus type 1 long terminal repeat (LTR) is an absolute requirement for transactivation by the human cytomegalovirus 72-kilodalton IE1 protein but can be compensated for by other LTR regions in tra |
| Q34130647 | A chromosome 12 coding region is juxtaposed to the MYC protooncogene locus in a t(8;12)(q24;q22) translocation in a case of B-cell chronic lymphocytic leukemia |
| Q70569969 | A conserved sequence at c-myc oncogene chromosomal translocation breakpoints in plasmacytomas |
| Q24530537 | A core-BRAF35 complex containing histone deacetylase mediates repression of neuronal-specific genes |
| Q33774162 | A critical role for cyclin C in promotion of the hematopoietic cell cycle by cooperation with c-Myc |
| Q35057224 | A growth-responsive gene (16C8) in normal mouse fibroblasts homologous to a human collagenase inhibitor with erythroid-potentiating activity: evidence for inducible and constitutive transcripts |
| Q24315939 | A helix-loop-helix protein related to the immunoglobulin E box-binding proteins |
| Q39551401 | A model to account for the effects of oncogenes, TPA, and retinoic acid on the regulation of genes involved in metastasis |
| Q41826773 | A negative transcriptional control element located upstream of the murine c-myc gene |
| Q24299387 | A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins |
| Q43684072 | A newly established metastatic breast tumor cell line with integrated amplified copies of ERBB2 and double minute chromosomes |
| Q24291788 | A novel c-Myc-responsive gene, JPO1, participates in neoplastic transformation |
| Q36796109 | A nuclease-hypersensitive element of the human c-myc promoter interacts with a transcription initiation factor. |
| Q34295816 | A role for secondary V(D)J recombination in oncogenic chromosomal translocations? |
| Q41100373 | A sequence in the 5' flanking region confers progestin responsiveness on the human c-myc gene |
| Q35818510 | A study of myc-related gene expression in small cell lung cancer by in situ hybridization. |
| Q35602831 | A translocated human c-myc oncogene is altered in a conserved coding sequence |
| Q59093573 | A variant translocation places the λ immunoglobulin genes 3′ to the c-myc oncogene in Burkitt's lymphoma |
| Q33932184 | Aberrant c-myc RNAs of Burkitt's lymphoma cells have longer half-lives |
| Q36791055 | Absence of missense mutations in activated c-myc genes in avian leukosis virus-induced B-cell lymphomas |
| Q36890641 | Accurate and efficient transcription of human c-myc genes injected into Xenopus laevis oocytes |
| Q37576047 | Activation of a translocated c-myc gene: role of structural alterations in the upstream region |
| Q34313568 | Activation of cellular oncogenes by chemical carcinogens in Syrian hamster embryo fibroblasts |
| Q40116365 | Activation of endogenous c-fos proto-oncogene expression by human T-cell leukemia virus type I-encoded p40tax protein in the human T-cell line, Jurkat |
| Q72083579 | Activation of nuclear protooncogenes and alpha‐fetoprotein gene in rat liver during the acute inflammatory reaction |
| Q36851181 | Activation of the transforming potential of the human fos proto-oncogene requires message stabilization and results in increased amounts of partially modified fos protein |
| Q40884711 | Advances in the diagnosis of acute leukemia. |
| Q24629980 | Alternative 5' exons either provide or deny an initiator methionine codon to the same alpha-tubulin coding region |
| Q24613262 | Alternative processing of RNA transcribed from NMYC |
| Q41090576 | Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma |
| Q55237135 | Amplification of both c-myc and c-raf-1 oncogenes in a human osteosarcoma. |
| Q47918368 | Amplification of the translocated c-myc genes in three Burkitt lymphoma cell lines |
| Q36691707 | An A + U-rich element RNA-binding factor regulates c-myc mRNA stability in vitro |
| Q36733279 | An amino-terminal c-myc domain required for neoplastic transformation activates transcription |
| Q36725327 | An initiation zone of chromosomal DNA replication located upstream of the c-myc gene in proliferating HeLa cells |
| Q39831901 | Analysis of gene expression during hematopoiesis: present and future applications |
| Q40452859 | Analysis of polyadenylation site usage of the c-myc oncogene. |
| Q43182303 | Analysis of the DNA-binding and dimerization activities of Neurospora crassa transcription factor NUC-1. |
| Q39542252 | Analysis of the c-myc IRES; a potential role for cell-type specific trans-acting factors and the nuclear compartment |
| Q41676906 | Analysis of thec-myc P2 promoter |
| Q69751026 | Application of RNA-RNA tissue in situ hybridization in an analysis of a patient with leukemia |
| Q59009274 | Arabidopsis thaliana contains two genes for TFIID |
| Q34769296 | Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation |
| Q36952471 | Augmented expression of normal c-myc is sufficient for cotransformation of rat embryo cells with a mutant ras gene |
| Q48056857 | Binding of THZif-1, a MAZ-like zinc finger protein to the nuclease-hypersensitive element in the promoter region of the c-MYC protooncogene |
| Q38352266 | Binding studies on peptide-oligonucleotide complex: intercalation of tryptophan in GC-rich region of c-myc gene. |
| Q40817188 | Bovine leukemia virus trans-activator p38tax activates heterologous promoters with a common sequence known as a cAMP-responsive element or the binding site of a cellular transcription factor ATF |
| Q36951697 | Burkitt lymphoma cell line carrying a variant translocation creates new DNA at the breakpoint and violates the hierarchy of immunoglobulin gene rearrangement |
| Q33881243 | C-myc expression is dissociated from DNA synthesis and cell division in Xenopus oocyte and early embryonic development |
| Q54438993 | C-myc gene binding factors in peripheral blood mononuclear cells from patients with systemic lupus erythematosus (SLE). |
| Q26738550 | Cancer Clocks Out for Lunch: Disruption of Circadian Rhythm and Metabolic Oscillation in Cancer |
| Q37406232 | Cardiac myocyte hypertrophy is associated with c-myc protooncogene expression |
| Q34534394 | Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene |
| Q28580913 | Characterization of rat c-myc and adjacent regions |
| Q36586570 | Characterization of the Bovine Prolactin Gene |
| Q36888721 | Characterization, expression, and evolution of the mouse embryonic zeta-globin gene |
| Q41338905 | Chromatin structure and function: the heretical path to an RNA transcription factor |
| Q33932005 | Chromatin structure of the murine c-myc locus: implications for the regulation of normal and chromosomally translocated genes. |
| Q35603098 | Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma |
| Q34589492 | Chromosomal location of the human gene for DNA polymerase beta. |
| Q33680724 | Chromosomal translocation in T-cell leukemia line HUT 78 results in a MYC fusion transcript |
| Q58420444 | Chromosome translocation can occur on either side of the c-myc oncogene in Burkitt lymphoma cells |
| Q78069915 | Cleavage of DNA by human NM23-H2/nucleoside diphosphate kinase involves formation of a covalent protein-DNA complex |
| Q69740105 | Clonal B cell expansions in patients with essential mixed cryoglobulinaemia |
| Q35769782 | Cloning and characterisation of therad9DNA repair gene fromSchizosaccharomyces pombe |
| Q36886353 | Cloning and sequencing of a c-myc oncogene in a Burkitt's lymphoma cell line that is translocated to a germ line alpha switch region |
| Q34381392 | Cloning of the chromosome translocation breakpoint junction of the t(14;19) in chronic lymphocytic leukemia |
| Q33558056 | Closely related transcripts encoded by the neurogenic gene complex enhancer of split of Drosophila melanogaster |
| Q40567159 | Clustered somatic mutations in and around first exon of non-rearranged c-myc in Burkitt lymphoma with t(8;22) translocation |
| Q36779697 | Complex translocation disrupts c-myc regulation in a human plasma cell myeloma |
| Q34668614 | Conservation and continuity of periodic bent DNA in genomic rearrangements between the c-myc and immunoglobulin heavy chain mu loci |
| Q39581697 | Control of myogenic differentiation by cellular oncogenes |
| Q28472991 | Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis |
| Q48112680 | Copy number alterations unmasked as enhancer hijackers |
| Q55279443 | Correlated expression of glutathione S-transferase-pi and c-Jun or other oncogene products in human squamous cell carcinomas of the head and neck: relevance to relapse after radiation therapy. |
| Q48376119 | Cultured human endothelial cells express platelet-derived growth factor B chain: cDNA cloning and structural analysis |
| Q41495304 | Cyclic AMP downregulates c-myc expression by inhibition of transcript initiation in human B-precursor Reh cells |
| Q36271956 | Cyclooxygenase (COX)-2 and granulosa cell apoptosis in vitro |
| Q36757293 | DNA-binding domain of human c-Myc produced in Escherichia coli. |
| Q36839982 | Definition of regions in human c-myc that are involved in transformation and nuclear localization |
| Q41519865 | Delineation of DNA replication time zones by fluorescence in situ hybridization |
| Q59095440 | Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation |
| Q36891965 | Deregulation of c-myc gene expression in human colon carcinoma is not accompanied by amplification or rearrangement of the gene |
| Q35248928 | Detection and cloning of new HTLV-related endogenous sequences in man |
| Q42621275 | Determination of heterogeneous transcription start points of two c-myc genes from the common carp (Cyprinus carpio). |
| Q35589318 | Development and regional expression of beta nerve growth factor messenger RNA and protein in the rat central nervous system |
| Q35789006 | Developmentally regulated alternative splicing in the Xenopus laevis c-Myc gene creates an intron-1 containing c-Myc RNA present only in post-midblastula embryos |
| Q28259742 | Differential expression of myogenic determination genes in muscle cells: possible autoactivation by the Myf gene products |
| Q35921774 | Differential expression of two Xenopus c-myc proto-oncogenes during development |
| Q36083463 | Differential patterns of DNA binding by myc and max proteins |
| Q36920022 | Differential promoter utilization by the c-myc gene in mitogen- and interleukin-2-stimulated human lymphocytes |
| Q36901237 | Diltiazem inhibits transferrin receptor expression and causes G1 arrest in normal and neoplastic T cells |
| Q36110185 | Discovery of a Family of Genomic Sequences Which Interact Specifically with the c-MYC Promoter to Regulate c-MYC Expression. |
| Q36789651 | Discrimination between related DNA sites by a single amino acid residue of Myc-related basic-helix-loop-helix proteins |
| Q36383062 | Dominant negative mutation in cell surface beta 1,4-galactosyltransferase inhibits cell-cell and cell-matrix interactions |
| Q33930099 | Driven by the same Ig enhancer and SV40 T promoter ras induced lung adenomatous tumors, myc induced pre-B cell lymphomas and SV40 large T gene a variety of tumors in transgenic mice |
| Q48389789 | Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphoma. |
| Q36676072 | Efficient Second-Strand cDNA Synthesis Using T7 DNA Polymerase |
| Q42168388 | Electrostatic interactions in leucine zippers: thermodynamic analysis of the contributions of Glu and His residues and the effect of mutating salt bridges |
| Q40514722 | Elongation and maturation of c-myc RNA is inhibited by differentiation inducing agents in HL60 cells |
| Q37691486 | Epigenetic mechanisms regulating normal and malignant haematopoiesis: new therapeutic targets for clinical medicine. |
| Q33784983 | Establishment and characterization of a human Epstein-Barr virus-associated gastric carcinoma in SCID mice |
| Q28277395 | Evidence for a molecular distinction between Golgi and cell surface forms of beta 1,4-galactosyltransferase |
| Q37595517 | Evidence that a triplex-forming oligodeoxyribonucleotide binds to the c-myc promoter in HeLa cells, thereby reducing c-myc mRNA levels |
| Q34585486 | Evolutionarily conserved regions of the human c-myc protein can be uncoupled from transforming activity |
| Q24608611 | Evolutionary variation of the CCAAT-binding transcription factor NF-Y |
| Q59066693 | Expression of a transfected human c-myconcogene inhibits differentiation of a mouse erythroleukaemia cell line |
| Q36364752 | Expression of c-MYC under the control of GATA-1 regulatory sequences causes erythroleukemia in transgenic mice |
| Q42508199 | Expression of c-myc in progenitor cells of the bronchopulmonary epithelium and in a large number of non-small cell lung cancers |
| Q40818267 | Expression of normal and translocated c-myc alleles in Burkitt's lymphoma cells: evidence for different regulation |
| Q70664029 | Expression of sequences related to c-myc in Entamoeba |
| Q36463664 | Expression of the c-myc proto-oncogene during development of Xenopus laevis |
| Q37540071 | Expression of the cytokeratin endo A gene during early mouse embryogenesis |
| Q37577006 | Extreme instability of myc mRNA in normal and transformed human cells. |
| Q36884122 | Family of developmentally regulated, maternally expressed Drosophila RNA species detected by a v-myc probe |
| Q36918435 | Features of the chicken c-myc gene that influence the structure of c-myc RNA in normal cells and bursal lymphomas |
| Q33646440 | From caveman companion to medical innovator: genomic insights into the origin and evolution of domestic dogs |
| Q33686865 | Functional diversity of gro gene expression in human fibroblasts and mammary epithelial cells |
| Q38313306 | Functional interaction of STAT3 transcription factor with the cell cycle inhibitor p21WAF1/CIP1/SDI1. |
| Q42818115 | Functional role for c-myc in mitogenic response to platelet-derived growth factor |
| Q54613997 | Further implications of the territorial effects of genes: chromosomal translocation and oncogene activation. |
| Q42835162 | Galectin-3: differential accumulation of distinct mRNAs in serum-stimulated mouse 3T3 fibroblasts. |
| Q40659481 | Generation of a variant t(2;8) translocation of Burkitt's lymphoma by site-specific recombination via the kappa light-chain joining signals |
| Q23913075 | Genotoxicity in workers exposed to methyl bromide |
| Q41750019 | Glucocorticoid hormones reduce the expression of major histocompatibility class I antigens on human epithelial cells |
| Q68890749 | H4 histone messenger RNA decay in cell-free extracts initiates at or near the 3' terminus and proceeds 3' to 5' |
| Q36787144 | Haploid-specific transcription of protamine-myc and protamine-T-antigen fusion genes in transgenic mice |
| Q35598211 | Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia |
| Q34689247 | High affinity interleukin 2 receptors in HTLV-1-infected T cells can mediate signals for gene expression. |
| Q30873773 | High resolution genome-wide analysis of chromosomal alterations in Burkitt's lymphoma |
| Q36964290 | High serum HTATIP2/TIP30 level in serous ovarian cancer as prognostic or diagnostic marker |
| Q64380415 | High-affinity binding site for a specific nuclear protein in the human IgM gene |
| Q41535694 | Hold back of RNA polymerase II at the transcription start site mediates down-regulation of c-myc in vivo |
| Q28299447 | Human N-myc is closely related in organization and nucleotide sequence to c-myc |
| Q34478553 | Human NM23/nucleoside diphosphate kinase regulates gene expression through DNA binding to nuclease-hypersensitive transcriptional elements |
| Q34177308 | Human aldolase A gene. Structural organization and tissue-specific expression by multiple promoters and alternate mRNA processing |
| Q39668510 | Human cancer and cellular oncogenes |
| Q33632309 | Human p53 oncogene contains one promoter upstream of exon 1 and a second, stronger promoter within intron 1. |
| Q35591132 | Human small-cell lung cancers show amplification and expression of the N-myc gene |
| Q28305879 | Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells |
| Q69351985 | Hypomethylation of the c-myc oncogene in liver cirrhosis and chronic hepatitis |
| Q70127641 | Identification of a c-myc oncogene lacking the exon 1 in the normal cells of a patient carrying a thyroid carcinoma |
| Q41040397 | Identification of a transforming growth factor-beta1/bone morphogenetic protein 4 (TGF-beta1/BMP4) response element within the mouse tissue transglutaminase gene promoter |
| Q34504751 | Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers |
| Q36560690 | Identification of sequences in c-myc mRNA that regulate its steady-state levels |
| Q36846194 | Identification of the human c-myc protein nuclear translocation signal |
| Q24531841 | Immunochemical detection of proteins related to the human c-myc exon 1 |
| Q36410698 | Improved long-distance polymerase chain reaction for the detection of t(8;14)(q24;q32) in Burkitt's lymphomas |
| Q36900424 | In vitro transcription analysis of the viral promoter involved in c-myc activation in chicken B lymphomas: detection and mapping of two RNA initiation sites within the reticuloendotheliosis virus long terminal repeat |
| Q35994429 | Increased expression of differentiation markers can accompany laminin-induced attachment of small cell lung cancer cells. |
| Q48324246 | Insertional mutagenesis of the myc locus by a LINE-1 sequence in a human breast carcinoma |
| Q37678291 | Interferon regulates c-myc gene expression in Daudi cells at the post-transcriptional level |
| Q38316694 | Interferons and Interleukin-6 Suppress the DNA-Binding Activity of E2F in Growth-Sensitive Hematopoietic Cells |
| Q24314719 | Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family |
| Q33880694 | Intragenic pausing and anti-sense transcription within the murine c-myc locus |
| Q40597117 | Inverted duplication of JH associated with chromosome 14 translocation and T-cell leukemia in ataxia-telangiectasia |
| Q42814918 | Involvement of Ca2+ in platelet-derived growth factor-induced expression of c-myc oncogene in Swiss 3T3 fibroblasts |
| Q33560874 | Isolation of an insulin-like growth factor II cDNA with a unique 5' untranslated region from human placenta |
| Q27860841 | Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product |
| Q41900816 | Kaposi sarcoma-associated herpesvirus vIRF-3 protein binds to F-box of Skp2 protein and acts as a regulator of c-Myc protein function and stability |
| Q36791112 | L-myc cooperates with ras to transform primary rat embryo fibroblasts |
| Q59081169 | L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer |
| Q38795442 | Lymphoma: current status of clinical and preclinical imaging with radiolabeled antibodies |
| Q89748900 | MYC Drives a Subset of High-Risk Pediatric Neuroblastomas and Is Activated through Mechanisms Including Enhancer Hijacking and Focal Enhancer Amplification |
| Q37302946 | MYC and gastric adenocarcinoma carcinogenesis |
| Q24611746 | MYC oncogene involved in a t(8;22) chromosome translocation is not altered in its putative regulatory regions |
| Q29619081 | Mammalian circadian biology: elucidating genome-wide levels of temporal organization |
| Q34061664 | Mammalian ribonucleotide reductase R1 mRNA stability under normal and phorbol ester stimulating conditions: involvement of a cis-trans interaction at the 3' untranslated region |
| Q44102149 | Mapping by chromosome sorting of several gene probes, including c-myc, to the derivative chromosomes of a 3;8 translocation associated with familial renal cancer |
| Q36259085 | Mapping of DNase I-hypersensitive sites in the upstream DNA of human embryonic epsilon-globin gene in K562 leukemia cells |
| Q33336043 | Mbh 1: a novel gelsolin/severin-related protein which binds actin in vitro and exhibits nuclear localization in vivo |
| Q37814672 | Mechanisms of a cellular decision during embryonic development of Drosophila melanogaster: epidermogenesis or neurogenesis |
| Q71367164 | Message of myc in context |
| Q35793698 | MicroRNA-146a modulates B-cell oncogenesis by regulating Egr1. |
| Q36602853 | MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies |
| Q61796276 | Mismatch repair-signature mutations activate gene enhancers across human colorectal cancer epigenomes |
| Q40418479 | Molecular analysis of both translocation products of a Philadelphia-positive CML patient |
| Q35414953 | Molecular biology in medicine |
| Q24324634 | Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease |
| Q36489739 | Molecular cloning and regulated expression of the human c-myc gene in Escherichia coli and Saccharomyces cerevisiae: comparison of the protein products |
| Q30983093 | Molecular cloning of calmodulin mRNA species which are preferentially expressed in neurons in the rat brain |
| Q33936373 | Molecular diagnostic approach to non-Hodgkin's lymphoma |
| Q57426191 | Molecular features of primary mediastinal B-cell lymphoma: involvement of p16INK4A, p53 and c-myc |
| Q30498610 | Molecular mechanisms of cancer |
| Q34819463 | Multiple functional elements comprise a Mammalian chromosomal replicator |
| Q36911215 | Multiple growth-associated nuclear proteins immunoprecipitated by antisera raised against human c-myc peptide antigens |
| Q36793456 | Multiple mechanisms for transcriptional regulation of the myc gene family in small-cell lung cancer |
| Q28776786 | Multiple single-stranded cis elements are associated with activated chromatin of the human c-myc gene in vivo |
| Q35604511 | Murine myb protooncogene mRNA: cDNA sequence and evidence for 5' heterogeneity |
| Q37512938 | Mutation-associated fusion cancer genes in solid tumors. |
| Q42575539 | Myelin proteolipid protein (PLP and DM-20) transcripts are deleted in jimpy mutant mice |
| Q24598505 | N-myc mRNA forms an RNA-RNA duplex with endogenous antisense transcripts |
| Q38301775 | NF-kappa B sites function as positive regulators of expression of the translocated c-myc allele in Burkitt's lymphoma |
| Q36772635 | Neoplastic transformation of mouse mammary epithelial cells by deregulated myc expression |
| Q40667918 | Neoplastic transformation of rat 3Y1 cells by a transcriptionally activated human c-myc gene and stabilization of p53 cellular tumor antigen in the transformed cells |
| Q34231849 | Norrie disease is caused by mutations in an extracellular protein resembling C-terminal globular domain of mucins |
| Q54413896 | Novel cytogenetic expression of gene amplification in actinomycin D-resistant somatic cell hybrids: transfer of resistance by centric chromatin bodies. |
| Q36897540 | Novel promoter upstream of the human c-myc gene and regulation of c-myc expression in B-cell lymphomas |
| Q40059017 | Nuclear colocalization of cellular and viral myc proteins with HSP70 in myc-overexpressing cells |
| Q37783683 | Nuclear imaging in three dimensions: A unique tool in cancer research |
| Q41145808 | Nucleosomal structure of active and inactive c-myc genes |
| Q37560488 | Nucleotide sequence 5' of the chicken c-myc coding region: localization of a noncoding exon that is absent from myc transcripts in most avian leukosis virus-induced lymphomas |
| Q33879878 | Nucleotide sequence of the coding region of the mouse N-myc gene |
| Q24632077 | Nucleotide sequence of the human N-myc gene |
| Q37685772 | Nucleotide sequence of two overlapping myc-related genes in avian carcinoma virus OK10 and their relation to the myc genes of other viruses and the cell |
| Q64039919 | Oligonucleotide Binding to Non-B-DNA in |
| Q39505491 | Oncogene amplification in tumor cells. |
| Q36987758 | Oncogene expression in vivo by ovarian adenocarcinomas and mixed-mullerian tumors |
| Q70356446 | Oncogenes--implications for human cancer: a review |
| Q59085650 | Oncogenesis: Paradox and paradigm: the message and meaning of myc |
| Q36766007 | Opposite replication polarity of the germ line c-myc gene in HeLa cells compared with that of two Burkitt lymphoma cell lines |
| Q24319866 | Organization and expression of the cell cycle gene, ts11, that encodes asparagine synthetase |
| Q46125111 | Patterns of genomic aberrations suggest that Burkitt lymphomas with complex karyotype are distinct from other aggressive B-cell lymphomas with MYC rearrangement |
| Q24654274 | Platelet-derived growth factor A chain: gene structure, chromosomal location, and basis for alternative mRNA splicing |
| Q36786995 | Poly(A) shortening and degradation of the 3' A+U-rich sequences of human c-myc mRNA in a cell-free system |
| Q42829394 | Possible involvement of pertussis toxin-sensitive GTP-binding protein(s) in c-fos expression during differentiation of 3T3-L1 fibroblasts to adipocytes |
| Q40818283 | Post-transcriptional mechanisms of deregulation of MYC following conversion of a human B cell line by Epstein-Barr virus |
| Q67740129 | Predicted Structural Similarities of the DNA Binding Domains of c-Myc and Endonuclease Eco RI |
| Q40423074 | Predicting antisense oligonucleotide inhibitory efficacy: a computational approach using histograms and thermodynamic indices |
| Q36835881 | Presence of a c-myc transcript initiated in intron 1 in Friend erythroleukemia cells and in other murine cell types with no evidence of c-myc gene rearrangement |
| Q70226528 | Production of a truncated human c-myc protein which binds to DNA |
| Q24564111 | Promoter region of the human platelet-derived growth factor A-chain gene |
| Q70464241 | Protein phosphatase 2A alpha involvement in granulocytic differentiation of HL-60 cells |
| Q42572125 | Proto-oncogene c-myc is expressed in cerebellar neurons at different developmental stages |
| Q41474997 | Proto-oncogene expression in a human chondrosarcoma cell line: HCS-2/8. |
| Q43954420 | Protooncogene Expression in Normal and Psoriatic Skin |
| Q38247850 | Protooncogenes and cell differentiation |
| Q33763715 | Purification of two transcription factors required for initiation by mammalian RNA polymerase II. |
| Q24629236 | Purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1 |
| Q36786682 | RAP30/74: a general initiation factor that binds to RNA polymerase II. |
| Q72874276 | Rapid alteration of c-myc and c-jun expression in leukemic cells induced to differentiate by a butyric acid prodrug |
| Q36925736 | Rapid cytoplasmic turnover of c-myc mRNA: requirement of the 3' untranslated sequences |
| Q40670672 | Rearrangement at the 5' end of amplified c-myc in human COLO 320 cells is associated with abnormal transcription |
| Q36843944 | Rearrangement of rat immunoglobulin E heavy-chain and c-myc genes in the B-cell immunocytoma IR162. |
| Q37333643 | Reflecting on 25 years with MYC. |
| Q40676274 | Regulation of the human c-myc gene: 5' noncoding sequences do not affect translation |
| Q37474961 | Regulation of transforming growth factor beta 1 gene expression by the product of the retinoblastoma-susceptibility gene |
| Q36841626 | Relatively stable population of c-myc RNA that lacks long poly(A). |
| Q36752763 | Retroviral transduction of the human c-Ha-ras-1 oncogene into midgestation mouse embryos promotes rapid epithelial hyperplasia |
| Q24310015 | Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor. |
| Q42096048 | Selective degradation of early-response-gene mRNAs: functional analyses of sequence features of the AU-rich elements |
| Q36255496 | Selective reduction of c-myc mRNA in Daudi cells by human beta interferon |
| Q24651262 | Sequence analysis of the MYC oncogene involved in the t(8;14)(q24;q11) chromosome translocation in a human leukemia T-cell line indicates that putative regulatory regions are not altered |
| Q30412414 | Sequence of a Drosophila segmentation gene: protein structure homology with DNA-binding proteins |
| Q39494892 | Sequence rearrangements and genome instability. A possible step in carcinogenesis |
| Q36900400 | Sequences involved in accurate and efficient transcription of human c-myc genes microinjected into frog oocytes |
| Q36350121 | Sequential expression of genes involved in human T lymphocyte growth and differentiation |
| Q36795479 | Serum-inducible expression of transfected human c-myc genes |
| Q38323202 | Single strand DNA specificity analysis of human nucleoside diphosphate kinase B. |
| Q30452239 | Site-directed mutagenesis of the gag-myc gene of avian myelocytomatosis virus 29: biological activity and intracellular localization of structurally altered proteins |
| Q47723106 | Somatic Superenhancer Duplications and Hotspot Mutations Lead to Oncogenic Activation of the KLF5 Transcription Factor. |
| Q34334050 | Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study |
| Q36138660 | Structural analysis of both products of a reciprocal translocation between c-myc and immunoglobulin loci in Burkitt lymphoma |
| Q36452794 | Structural and functional analysis of the promoter region of the nerve growth factor gene |
| Q36945187 | Structure and Expression of the Oncogene c-myc in Fresh Tumor Material from Patients with Hematopoietic Malignancies |
| Q24632930 | Structure and expression of the human L-myc gene reveal a complex pattern of alternative mRNA processing |
| Q33929818 | Structure and expression of the murine L-myc gene. |
| Q35595448 | Structure and expression of the murine N-myc gene |
| Q35599098 | Structure and sequence of the human c-sis/platelet-derived growth factor 2 (SIS/PDGF2) transcriptional unit |
| Q36587310 | Structure of the polymorphic feline c-myc oncogene locus |
| Q35884433 | Study of C-MYC amplification and expression in Iranian gastric cancer samples using CISH and IHC methods |
| Q36891678 | Synthesis of predominantly unspliced cytoplasmic RNAs by chimeric herpes simplex virus type 1 thymidine kinase-human beta-globin genes |
| Q24602693 | TFEC, a basic helix-loop-helix protein, forms heterodimers with TFE3 and inhibits TFE3-dependent transcription activation |
| Q28255619 | TIP30 interacts with an estrogen receptor alpha-interacting coactivator CIA and regulates c-myc transcription |
| Q40658950 | Target sequences for cis-acting regulation within the dual promoter of the human c-myc gene |
| Q34391522 | Targeting c-Myc as a novel approach for hepatocellular carcinoma |
| Q35766912 | Testis-specific expression of the human MYCL2 gene |
| Q44116807 | The Drosophila extramacrochaetae locus, an antagonist of proneural genes that, like these genes, encodes a helix-loop-helix protein |
| Q24305931 | The HeLa Pur factor binds single-stranded DNA at a specific element conserved in gene flanking regions and origins of DNA replication |
| Q93333197 | The MYC Enhancer-ome: Long-Range Transcriptional Regulation of MYC in Cancer |
| Q52715807 | The Role for Myc in Coordinating Glycolysis, Oxidative Phosphorylation, Glutaminolysis, and Fatty Acid Metabolism in Normal and Neoplastic Tissues. |
| Q36804661 | The activated Notch1 receptor cooperates with alpha-enolase and MBP-1 in modulating c-myc activity. |
| Q37013896 | The c-myc promoter: still MysterY and challenge |
| Q28206180 | The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo |
| Q34808300 | The expression pattern of Id4, a novel dominant negative helix-loop-helix protein, is distinct from Id1, Id2 and Id3 |
| Q33881231 | The first exon of the c-myc proto-oncogene contains a novel positive control element. |
| Q24627389 | The human L-myc gene encodes multiple nuclear phosphoproteins from alternatively processed mRNAs |
| Q47687352 | The mRNA expression of the human 1,25-dihydroxyvitamin D3 receptor and the c-myc protooncogene in cultured human keratinocytes |
| Q36550587 | The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation |
| Q37580071 | The protein encoded by the human proto-oncogene c-myc |
| Q39818292 | The role of c-myc in the proliferation of normal and neoplastic cells |
| Q34616409 | The role of oncogenes in gastrointestinal cancer |
| Q33866905 | The spfash mouse: a missense mutation in the ornithine transcarbamylase gene also causes aberrant mRNA splicing |
| Q28302430 | The transcription factor, Nm23H2, binds to and activates the translocated c-myc allele in Burkitt's lymphoma |
| Q42941517 | Trans-splicing as a possible molecular mechanism for the multiple isotype expression of the immunoglobulin gene |
| Q36385496 | Transcription and cancer |
| Q38334324 | Transcription factor binding and induced transcription alter chromosomal c-myc replicator activity |
| Q34173877 | Transcription factors and translocations in lymphoid and myeloid leukemia |
| Q34561684 | Transcriptional activation and DNase I hypersensitive sites are associated with selective expression of the gastrin-releasing peptide gene |
| Q67992642 | Transcriptional deregulation of myc in IgH/myc 6;7 translocation carrying rat immunocytomas |
| Q41637744 | Transcriptional down-regulation of c-myc in human prostate carcinoma cells by the synthetic androgen mibolerone |
| Q36844168 | Transcriptional inactivation of c-myc and the transferrin receptor in dibutyryl cyclic AMP-treated HL-60 cells |
| Q34277622 | Transcriptional protein Sp1 regulates LEDGF transcription by directly interacting with its cis-elements in GC-rich region of TATA-less gene promoter |
| Q33879996 | Transformation of quail embryo fibroblasts by a retrovirus carrying a normal human c-myc gene |
| Q36919159 | Transforming potential of a myc-containing variant of feline leukemia virus in vitro in early-passage feline cells |
| Q33640664 | Transgenic mice bearing the human c-myc gene activated by an immunoglobulin enhancer: a pre-B-cell lymphoma model |
| Q35580639 | Transient elevation of messenger RNA encoding gastrin-releasing peptide, a putative pulmonary growth factor in human fetal lung |
| Q36779760 | Translation of the placenta growth factor mRNA is severely affected by a small open reading frame localized in the 5' untranslated region |
| Q36949121 | Translational Efficiency of cMyc mRNA in Burkitt Lymphoma Cells |
| Q37566467 | Translocation and rearrangement of c-myc into immunoglobulin alpha heavy chain locus in primary cells from acute lymphocytic leukemia |
| Q42567576 | Translocation of c-myc into the immunoglobulin heavy-chain locus in human acute B-cell leukemia. A molecular analysis |
| Q40463180 | Trasiocation affects normalc-mycpromoter usage and activates fifteen crypticc-myctranscription starts in plasmacytoma M603 |
| Q41349782 | Truncation does not abrogate transcriptional downregulation of the c-myc gene by sodium butyrate in Burkitt's lymphoma cells |
| Q31038932 | Tumor-specific usage of alternative transcription start sites in colorectal cancer identified by genome-wide exon array analysis |
| Q36908146 | Tumorigenicity of fibroblast lines expressing the adenovirus E1a, cellular p53, or normal c-myc genes |
| Q40646003 | Two N-myc polypeptides with distinct amino termini encoded by the second and third exons of the gene |
| Q36783817 | Two distinct mechanisms of transcriptional control operate on c-myc during differentiation of HL60 cells |
| Q64998413 | [The molecular pathogenesis of small cell lung cancer]. |
| Q33968356 | c-Myc is a critical target for c/EBPalpha in granulopoiesis. |
| Q33961819 | c-Myc protein synthesis is initiated from the internal ribosome entry segment during apoptosis. |
| Q33956988 | c-Myc target genes involved in cell growth, apoptosis, and metabolism |
| Q41586386 | c-myc and immunoglobulin kappa light chain constant genes are on the 8q+ chromosome of three Burkitt lymphoma lines with t(2;8) translocations |
| Q41830956 | c-myc protein distribution. Neoplastic tissues of the human colon |
| Q35750118 | eIF-4E expression and its role in malignancies and metastases. |
| Q33601639 | eIF4E expression in tumors: its possible role in progression of malignancies |
| Q34574984 | myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course |
| Q37511853 | myc family oncogenes in the development of normal and neoplastic cells. |
Search more.